🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Important work by txid ⭐️ Jessica Little, MD ESCMID infection density increases after bsAb therapy, more opportunistic & life-threatening infections! Come chat p3777!

A full house at Ben Teh #ECCMID2024 ESCMID discussing vaccine strategies. We aren’t doing as well as we think. Complex schedules, lack of clarity in responsibilities and access to info. Some principles and strategies to implement…NCIC Tori Hall

NATASHA HALASA Halasa Lab presents a comprehensive presentation on MAbs - starting with the history of their development.

Master class in MDROs - risks, prevention and management in SOT BY Maddalena Giannella ECCMID ESCMID

Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape mdpi.com/2725978 #mdpiviruses via Viruses MDPI

Another great session on infections and infectious diseases in immucompromised patients ⁦ESCMID⁩ #escmidglobal2024 - including on virus-specific T cell therapy by Nina Khanna, Basel, Switzerland 🤩👍

#ECCMID2024 The role of combination anti fungals in session on controversies in anti fungal monica slavin NCIC . Lack of good evidence… perhaps in cases of very poor outcome, how best to measure response though? New orals coming out … Combination potential ? ESCMID

A global call to encourage the use of standard reporting of infection AEs so we can advance research in the field. It was also mentioned at #ESCMIDGlobal2024

Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy 🔓 Open Access bit.ly/3UOE6Co

Check out our new review article in The Lancet Haematology ⤵️ “Immune effector cell-associated hematotoxicity after CAR T-cell therapy: from mechanism to management” ➡️ We summarize all that we currently know and understand about CAR-T related cytopenias. thelancet.com/journals/lanha…

【Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant】Curr Opin Infec Dis 2024 May 7 👉Important review article! 👉I really like Figure 1 and Table 1! Erika Kampouri Jessica Little, MD Joshua Hill, MD journals.lww.com/co-infectiousd…

Publication Alert 🚨 Clinical Mycology Today: Emerging Challenges and Opportunities 🤩Editor’s Choice🤩 Perspectives on current status and future of clinical mycology inspired by discussions at #msgerc2022, our biennial meeting academic.oup.com/ofid/advance-a…

Interesting how many of these infections were not specified in terms of diagnosis! We NEED improved diagnostics and infection reporting to better understand how to prevent and manage infections in this setting! Erika Kampouri Joshua Hill, MD Bilal Abid, MD, MS

【Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections】Curr Opin Infect Dis, Oct 5 2024 👉Congrats, Erika Erika Kampouri Fred Hutch Cancer Center Université de Lausanne🎉 👉Comprehensive review on the epidemiology of viral infections and critical approaches to

Interested in learning about the cutting edge in management of infections in HCT, CAR-T, and SOT recipients? Pls mark your calendars for May 11-14, 2025, for the 5th symposium on infections in immunocompromised individuals. Travel stipends available! bit.ly/4hgyLwS

fredhutch.org/content/www/en… via Fred Hutch Cancer Center With increasing infectious disease threats plus a growing population of people with weakened immune systems, we think the time is right to establish a national network dedicated to trials at this intersection.

I know you’ve all been on tenterhooks, awaiting the dramatic conclusion to “How PCP Became PJP”. Well here it is. You’ll laugh! You’ll cry! And you’ll finish reading it so much better informed about this critical debate. NEJM Journal Watch NEJM blogs.jwatch.org/hiv-id-observa…

Off-the-Shelf Allogeneic Natural Killer (NK) Cells for the Treatment of COVID-19: Molecular Therapy Methods & Clinical Development cell.com/molecular-ther… We need continued investment in development of cellular therapies for infectious diseases Fred Hutch Cancer Center ASTCT HutchIDSciences

Congratulations to Alina Stavroula Kampouri, Rice U. Chemical & Biomolecular Engineering assistant professor, for receiving a $110,000 Petroleum Research Fund grant from the American Chemical Society to support research in metal-organic frameworks. bit.ly/3YY2vXl

Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. onlinelibrary.wiley.com/doi/10.1111/ti…